CO-AX Accelerator at Sahlgrenska Science Park recognized as a leading incubator in Sweden
Sahlgrenska Science Park’s CO-AX Accelerator has been ranked among the top incubators in Sweden within Vinnova’s national excellence incubator program. Vinnova, Sweden’s Innovation Agency, has announced that CO-AX Accelerator has been recognized as an "Excellent Incubator" and has been awarded SEK 22 million over four years.
Publish date:2025-02-11
"We are incredibly proud to secure this top position and funding, as it enables us to further strengthen our support for innovative startups. Vinnova’s recognition reaffirms CO-AX as a top-tier incubator, accelerating health innovation and enabling future life-saving solutions,” says Cecilia Edebo, CEO of Sahlgrenska Science Park.
Vinnova’s national excellence incubator program aims to strengthen Swedish incubators that support innovative startups. Through this program, incubators receive funding and a quality stamp, signaling that they meet high standards in business development, networking and growth acceleration.
"This recognition validates the impact of our daily work with startups to drive innovation and growth. The quality stamp confirms that we provide high-quality support to life science entrepreneurs, and with this funding, we can further enhance the conditions for the next generation of businesses," continues Cecilia Edebo.
The largest tech startup ecosystem for health innovation in the Nordics
The CO-AX Acceleratoris the largest tech startup ecosystem for health innovation in the Nordics and is dedicated to building high-impact companies within life science, healthtech, and medtech, helping them scale globally.
As an integral part of Sahlgrenska Science Park, CO-AX provides strategic support and commercialization expertise in collaboration with leading universities, healthcare institutions, and industry partners.
With a strong portfolio of startupsand a track record of enabling business growth and international expansion, CO-AX’s mission is to support tech innovations that address global health challenges.
"Our team of experts in business development, financing, internationalization, intellectual property and regulatory affairs plays a key role in the success of the companies we support. With Vinnova’s continued backing, we look forward to scaling even more cutting-edge healthtech startups globally," concludes Emma Hallenberg, Director CO-AX at Sahlgrenska Science Park.
===
Applications are currently open for the CO-AX Accelerator spring 2025 cohort. Click here to apply and to learn more.
